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Introduction
Silica particles are the key abrasive scouring agents in tooth-
pastes that facilitate the removal of bacteria (Barbe et al. 2004; 
Brunner et al. 2006; Riccio and Schoenfisch 2012). Recent evi-
dence suggests that polishing with nanoparticles versus 
micron-sized silica helps decrease the surface roughness of 
teeth and further lessens the strength of bacterial adhesion, 
making Streptococcus mutans removal easier (Gaikwad and 
Sokolov 2008). Although effective at reducing overall bacte-
rial counts, silica nanoparticles are not inherently antimicro-
bial. Various materials, including fibers, gels, polymers, and 
microspheres, modified to release antibiotics (e.g., minocy-
cline), have demonstrated promise for the treatment of oral 
diseases (Greenstein and Polson 1998; Williams et al. 2001). 
Unfortunately, these materials are less suitable for the physical 
removal of plaque-forming bacteria. While local drug delivery 
systems may limit the risk of systemic side effects (e.g., pseu-
domembranous colitis) (Radvar et al. 1996; Williams et al. 
2001), the overuse of antibiotics fosters antibiotic-resistant 
pathogens (Kinane and Radvar 1999). The combination of sil-
ica (as a polishing agent) with new antibacterial agents that do 
not foster bacterial resistance could potentially lead to 
improved therapeutics for treating periodontal disease and 
dental caries that are easily implemented into existing dental 
hygiene practices (i.e., teeth brushing).
Nitric oxide (NO) is a gaseous free radical produced endog-
enously during the immune response to invading organisms 
(Bogdan 2001). In oral biology, both bacteria and proinflam-
matory stimuli present in dental plaque biofilms elicit the gen-
eration of NO from oral mucosal epithelial cells (Carossa et al. 
2001). The antibacterial activity of NO is attributed to reactive 
by-products causing oxidative and nitrosative stresses on bac-
teria. For example, NO reacts with superoxide to form per-
oxynitrite, which elicits significant membrane damage via 
lipid peroxidation, while reaction with oxygen produces dini-
trogen trioxide, a nitrosative species that disables protein func-
tion (Hetrick and Schoenfisch 2006). With broad-spectrum 
activity and no observed bacterial resistance to date (Privett 
et al. 2012; Schairer et al. 2012), the delivery of exogenous NO 
is a promising antibacterial for oral care. Although NO produced 
via the acidification of nitrite has bactericidal properties against 
cariogenic (Silva Mendez et al. 1999) and periodontopathogenic 
bacteria (Allaker et al. 2001), precise control over NO genera-
tion is pivotal in designing effective antibacterial delivery sys-
tems (Barbe et al. 2004; Carpenter and Schoenfisch 2012).
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Abstract
Nitric oxide (NO)–releasing silica nanoparticles were synthesized via the co-condensation of tetramethyl orthosilicate with aminosilanes 
and subsequent conversion of secondary amines to N-diazeniumdiolate NO donors. A series of ~150 nm NO-releasing particles 
with different NO totals and release kinetics (i.e., half-lives) were achieved by altering both the identity and mol% composition of 
the aminosilane precursors. Independent of identical 2 h NO-release totals, enhanced antibacterial action was observed against the 
periodontopathogens Aggregatibacter actinomycetemcomitans and Porphyromonas gingivalis with extended NO-release kinetics at pH 7.4. 
Negligible bactericidal effect was observed against cariogenic Streptococcus mutans at pH 7.4, even when using NO-releasing silica 
particles with greater NO-release totals. However, antibacterial activity was observed against S. mutans at lower pH (6.4). This result 
was attributed to more rapid proton-initiated decomposition of the N-diazeniumdiolate NO donors and greater NO-release payloads. 
The data suggest a differential sensitivity to NO between cariogenic and periodontopathogenic bacteria with implications for the future 
development of NO-releasing oral care therapeutics.
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Shin et al. (2007) first reported the Stöber (Stöber et al. 
1968) synthesis of hybrid NO-releasing silica nanoparticles of 
varying size (20–500 nm). The aminosilane composition (10–
87 mol%) of the silica nanoparticles was tunable, which enabled 
a thorough evaluation of NO’s utility against Gram-positive, 
Gram-negative, and fungal biofilms (Shin et al. 2007; Hetrick 
et al. 2009). Subsequent research has focused on studying the 
physicochemical properties (e.g., size, shape, and release kinet-
ics) of NO donor-modified silica nanoparticles to maximize 
bactericidal efficacy. Carpenter et al. (2011) observed that 
~50 nm NO-releasing silica particles were more effective at 
killing bacteria than larger particles (e.g., 100 and 200 nm) due 
to enhanced diffusion and faster bacteria-particle association. 
Lu et al. (2013) described the synthesis of NO-releasing silica 
rods, noting improved bactericidal activity for oblong over 
spherical particles due to increased bacteria/particle surface 
contact and intracellular NO delivery. In the same study, a 
greater initial NO flux showed improved killing, suggesting 
that faster NO-release kinetics may enhance NO’s antibacterial 
activity against Pseudomonas aeruginosa (Lu et al. 2013). To 
date, the antibacterial activity of NO-releasing silica nanoparti-
cles as a function of NO-release kinetics has not been system-
atically evaluated, particularly against oral pathogens.
Herein, we investigated the influence of NO-release kinet-
ics on bactericidal efficacy against common periodontopatho-
gens independent of particle size and NO-release totals. 
Comparatively, the kinetic-dependent killing of a cariogenic 
strain was also examined using a single NO-releasing silica 
particle system with greater NO-release totals.
Materials and Methods
Materials
Materials are described in the Appendix.
Synthesis of NO-releasing Silica Particles
The Stöber co-condensation of aminosilanes with alkoxysilanes 
was used to create secondary amine-modified silica particles. 
Briefly, hybrid particles were synthesized by combining tetra-
methyl orthosilicate (TMOS) with an aminosilane (3-methyl-
aminopropyltrimethoxysilane [MAP3], N-(6-aminohexyl)
aminopropyltrimethoxysilane [AHAP3], and N-(2-aminoethyl)-
3-aminopropyltrimethoxysilane [AEAP3]) and injection of the 
silane mixture into a flask containing water, ammonium hydrox-
ide, and EtOH; stirring for 2 h under ambient conditions; and 
collecting via centrifugation. Secondary amines were converted 
to N-diazeniumdiolate NO donors under high pressures of NO 
gas in basic conditions. The control and NO-releasing silica 
particles were characterized using dynamic light scattering, 
scanning electron microscopy, carbon, hydrogen, and nitrogen 
(CHN) elemental analysis, and chemiluminescent nitric oxide 
detection. Complete synthesis and characterization of 
NO-releasing hybrid silica nanoparticles are described in the 
Appendix.
Bactericidal Assays
Complete bacterial growth is described in the Appendix. 
Briefly, Streptococcus mutans, Aggregatibacter actinomy-
cetemcomitans, and Porphyromonas gingivalis were grown to 
108 colony-forming units (CFU)/mL, pelleted via centrifuga-
tion, and diluted to 106 CFU/mL. Bacteria solutions were 
added to vials containing either NO-releasing or control silica, 
sonicated, and incubated aerobically at 37 °C with moderate 
shaking. After 2 h, these solutions were diluted and spiral-
plated using an Eddy Jet spiral plater (IUL, Farmingdale, NY, 
USA) on BHI agar or Wilkins-Chalgren agar (P. gingivalis) 
and incubated at 37 °C under aerobic (S. mutans, 3 d), micro-
aerophilic (A. actinomycetemcomitans, 2 d), or anaerobic (P. 
gingivalis, 4 d) conditions. Viable colonies were enumerated 
on agar plates using a Flash and Go colony counter (IUL). The 
concentration resulting in a 3-log reduction in bacterial viabil-
ity to below 2.5 × 103 CFU/mL (limit of detection for the plat-
ing method) (Breed and Dotterrer 1916) was determined to be 
the minimal bactericidal concentration (MBC
2h
).
Confocal Microscopy for Intracellular  
NO Detection
Confocal microscopy assays for the detection of intracellular 
NO in planktonic cultures of A. actinomycetemcomitans and 
S. mutans are described in the Appendix.
In Vitro Cytotoxicity
Human gingival fibroblasts (HGF-1) were grown in Dulbecco’s 
modified Eagle’s medium (DMEM) supplemented with 10% 
(v/v) fetal bovine serum (FBS) and 1 wt% penicillin streptomy-
cin (PS) and incubated at 37 °C under humidified conditions in 
5% CO
2
 (v/v). At 80% confluency, cells were trypsinized, seeded 
onto a tissue culture–treated 96-well plate, and incubated at 
37 °C. Solutions of control and NO-releasing silica particles (8, 
32, and 48 mg/mL for 80 mol% AEAP3, 60 mol% AHAP3, and 
50 mol% MAP3, respectively) in DMEM were added to the 
cells before a 2 h incubation at 37 °C. The supernatant was then 
aspirated, and 120 µL DMEM/phenazine methosulfate (PMS)/3-
(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium inner salt (MTS) solution (100/20/1 
v/v/v) was added to the wells. After a 2 h incubation at 37 °C, 
100 µL from each well was transferred to a new microtiter plate. 
A Multiskan EX plate reader (Thermo Scientific, Waltham, MA, 
USA) was used to measure the absorbance at 490 nm. The 
absorbance measurements were blank-subtracted, and cell via-
bility was quantified relative to untreated cells.
Results
Hybrid alkoxysilane/aminosilane silica nanoparticles were 
synthesized via the Stöber method (Stöber et al. 1968). Through 
careful variation of the synthetic reaction parameters, MAP3, 
AHAP3, and AEAP3 silica nanoparticles were produced to 
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have similar geometric diameters (~150 nm) and a high degree 
of monodispersity, as indicated by the low polydispersity index 
(PDI) values (≤0.06; Appendix). Successful incorporation of 
the aminosilanes was confirmed via CHN elemental analysis 
with an increase in nanoparticle nitrogen wt% (3.42, 4.28, and 
5.83 wt% for MAP3, AHAP3, and AEAP3, respectively; 
Appendix). The positively charged (i.e., protonated) surface 
amines of the particles resulted in positive zeta potentials 
(Appendix). In Tris–phosphate-buffered saline (PBS) (pH 7.4), 
MAP3 and AEAP3 particles were characterized as having sim-
ilar zeta potentials (~20 mV), while AHAP3 particles exhibited 
a greater positive surface charge (31.4 mV).
NO release from MAP3, AHAP3, and AEAP3 particles was 
characterized using chemiluminescence in PBS (pH 7.4) at 
37 °C to obtain NO-release totals and kinetics (i.e., half-lives) 
(Coneski and Schoenfisch 2012). The total NO release for the 
MAP3, AHAP3, and AEAP3 particles was 0.22, 0.25, and 
0.39 µmol/mg, respectively (Table). Of importance, the 2 h 
NO-release totals were similar (~0.20 µmol/mg) across all 3 
particle systems and representative of the NO concentration 
delivered during the 2 h bacteria killing assays. The NO-release 
half-lives were also similar for MAP3 and AHAP3 (~32 min) 
but significantly longer for AEAP3 (112.5 min).
To study the role of NO-release kinetics and particle surface 
charge on bactericidal efficacy, 2 h bacteria killing assays were 
conducted against periodontopathogens in Tris-PBS (pH 7.4; 
37 °C). Lower bactericidal concentrations (MBC
2h
) were 
observed for AHAP3 over MAP3 particles against both A. acti-
nomycetemcomitans (32 vs. 48 mg/mL, respectively) and 
P. gingivalis (16 vs. 32 mg/mL, respectively) (Figure 1). The 
bactericidal concentrations for NO-releasing AEAP3 were 8 
mg/mL against both periodontopathogens, corresponding to a 
bactericidal NO dose of 1.6 µmol/mL. This NO dose is reduced 
from that of NO-releasing MAP3 (9.1 and 6.1 µmol/mL against 
A. actinomycetemcomitans and P. gingivalis, respectively). 
Human gingival fibroblasts (HGF-1) were used to evaluate the 
toxicity of NO-releasing and control silica particles at bacteri-
cidal concentrations. The toxicity of control particles increased 
(i.e., decreased cell viability) as a function of the silica concen-
tration (Figure 2). For the AHAP3 and MAP3 particle systems, 
NO release further decreased cell viability (31% and 21% rela-
tive to untreated cells). The addition of NO release for the 
AEAP3 system, however, improved HGF-1 viability to rela-
tively nontoxic levels (>80% viability).
Due to the decreased sensitivity of the cariogenic pathogen 
S. mutans to NO (Backlund et al. 2014), the NO storage for the 
most rapid NO-releasing system (MAP3) was increased to 
~1 µmol/mg. Bactericidal assays were performed at both pH 
7.4 and 6.4 to evaluate the effects of faster NO-release kinetics 
on biocidal action. At pH 6.4, MAP3 NO-release kinetics were 
more rapid as N-diazeniumdiolate donors decompose faster 
with increasing proton concentration, resulting in a greater ini-
tial NO flux (9,200 to 25,800 ppb/mg) and shorter half-life 
(19.8 to 4.5 min) (Table). The zeta potential for MAP3 parti-
cles at pH 6.4 (26.3 mV) also indicated a greater positive 
charge, due to greater amine protonation at lower pH. While 
increasing the total NO payload at pH 7.4 did not enhance 
S. mutans killing by NO-releasing MAP3 particles, complete 
eradication of S. mutans (i.e., 3-log reduction in viability) at 
pH 6.4 was achieved with 32 mg/mL MAP3 particles 
(Appendix).
Discussion
In this study, we synthesized NO-releasing silica nanoparticles 
of varying aminosilane identity and composition (50 mol% 
MAP3, 60 mol% AHAP3, and 80 mol% AEAP3) to investigate 
the role of NO-release kinetics on the killing of periodontal 
pathogens. For clarity, the particle systems are referred to as 
MAP3, AHAP3, and AEAP3. Synthetic parameters were tuned 
to produce monodisperse nanoparticles with similar geometries 
and diameters. Maintaining a constant size was crucial as this 
parameter has been shown to influence bactericidal efficacy 
(Carpenter et al. 2011). Incorporating different aminosilanes 
into the nanoparticles allowed us to investigate the effects of 
particle surface charge on bactericidal action, with AHAP3 par-
ticles exhibiting a greater positive surface charge than either 
MAP3 or AEAP3. Furthermore, as the kinetics of proton- 
initiated N-diazeniumdiolate decomposition from NO donors are 
dependent on structure (Shin et al. 2007), NO-release kinetics 
Table. Characterization of NO-Releasing Silica Particles in Phosphate-Buffered Saline (pH 6.4 or 7.4, 37 °C) as Measured by a Chemiluminescence 
NO Analyzer.







50% MAP3 7.4 0.22 ± 0.04 900 ± 300 31.6 ± 6.7 0.19 ± 0.04
60 % AHAP3 7.4 0.25 ± 0.05 1,700 ± 1,000 33.8 ± 5.5 0.21 ± 0.04
80% AEAP3 7.4 0.39 ± 0.05 1,400 ± 200 112.5 ± 18.0 0.20 ± 0.02
70% MAP3 7.4 0.84 ± 0.14 9,200 ± 4,300 19.8 ± 3.3 0.81 ± 0.15
70% MAP3 6.4 0.95 ± 0.17 25,800 ± 7,500 4.5 ± 0.2 0.95 ± 0.17
Results shown for 50 mol% MAP3, 60 mol% AHAP3, 80 mol% AEAP3, and 70 mol% MAP3 NO-releasing silica particles and presented as mean ± 
standard deviation for n = 3 or more pooled experiments. AEAP3, N-(2-aminoethyl)-3-aminopropyltrimethoxysilane; AHAP3, N-(6-aminohexyl)




dTotal NO released after 2 h.
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were varied with aminosilane identity 
as well. The significantly longer 
NO-release half-life observed for 
AEAP3 over MAP3 or AHAP3 parti-
cles is due to N-diazeniumdiolate sta-
bilization via hydrogen bonding with 
neighboring cationic amines on the 
AEAP3 scaffold (Lu et al. 2011). The 
ability to tune both the identity and 
degree of silica nanoparticle aminosi-
lane functionalization while maintain-
ing constant geometric diameters 
decoupled particle size–mediated kill-
ing from NO release and particle sur-
face charge. The bactericidal efficacy 
of MAP3 and AEAP3 was thus com-
pared as a function of NO-release 
kinetics, independent of particle size, 
surface charge, and 2 h NO-release 
totals. The influence of particle sur-
face charge was compared between 
MAP3 and AHAP3 particles, inde-
pendent of NO-release kinetics. 
Last, we evaluated the importance 
of increased positive particle sur-
face charge (AHAP3) versus 
extended NO-release kinetics 
(AEAP3) on periodontopathogen 
killing.
As expected from our previous 
work (Backlund et al. 2014), both 
A. actinomycetemcomitans and P. 
gingivalis were readily susceptible to 
NO, with bactericidal NO doses of 
<10 µmol/mL (Fig. 1). However, 
bactericidal efficacy was also depen-
dent on both NO-release kinetics and 
particle surface charge. Increased 
bactericidal action was observed for 
AHAP3 over MAP3 particles against 
both periodontopathogens. Due to 
the similar NO-release half-lives 
(~32 min) of these systems, the 
improved bactericidal efficacy of AHAP3 was attributed to the 
increased particle surface charge (31.4 vs. 20.9 mV for AHAP3 
and MAP3, respectively). Greater positive surface charge 
enhances particle- bacteria association (Aoki et al. 2012) and 
most likely increases the buildup of intracellular NO and thus 
NO-mediated death. Confocal micro scopy and the fluorescent 
probe DAF-2 DA confirmed greater NO delivery to A. actino-
mycetemcomitans from AHAP3 versus MAP3 particles over a 
30 to 120 min window (Fig. 3). In contrast, intracellular NO 
from the MAP3 particle system was observed only after 120 
min. The improved antibacterial activity of NO-releasing 
AHAP3 over MAP3 particles is thus attributed to the more 
efficient delivery of NO with increasing surface charge.
The most effective killing of periodontopathogens was 
observed for NO-releasing AEAP3 particles (Fig. 1). We 
hypothesized that the extended NO-release kinetics (i.e., half-
lives) characteristic of AEAP3 (112.5 min) compared with 
MAP3 (31.6 min) particles facilitated the enhanced killing. 
Intracellular NO fluorescence was observed for the AEAP3 
particle system after only 30 min of exposure to A. actinomy-
cetemcomitans compared with MAP3, which required 120 min 
for any visible fluorescence (Fig. 3). Furthermore, the intracel-
lular NO from AEAP3 increased to a maximum at 60 min 
before decreasing at 120 min, coinciding with outer membrane 
decomposition and bacterial death (Hetrick et al. 2008; 
Slomberg et al. 2013).
Figure 1. Bactericidal efficacy of (A) 50 mol% 3-methylaminopropyltrimethoxysilane (MAP3)  
particles, (B) 60 mol% N-(6-aminohexyl)aminopropyltrimethoxysilane (AHAP3) particles, and  
(C) 80 mol% N-(2-aminoethyl)-3-aminopropyltrimethoxysilane (AEAP3) particles against Aggregatibacter 
actinomycetemcomitans in Tris–phosphate-buffered saline (PBS) (pH 7.4) after 2 h. Bactericidal efficacy of 
(D) 50 mol% MAP3 particles, (E) 60 mol% AHAP3 particles, and (F) 80 mol% AEAP3 particles against 
Porphyromonas gingivalis in Tris-PBS (pH 7.4) after 2 h. Nitric oxide (NO)–releasing material denoted 
by rectangles (■) and non-NO-releasing controls denoted by circles (●). Error bars signify standard 
deviation of the mean bacterial viability (colony-forming units [CFU]/mL). For all measurements, n = 3 
or more pooled experiments.
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The antibacterial activity of NO-releasing AHAP3 and 
AEAP3 particles was compared to evaluate the relative impor-
tance of increased positive particle surface charge versus 
extended NO-release kinetics for enhancing the bactericidal 
efficacy of NO-releasing silica particles. Despite the decreased 
particle surface charge for AEAP3 versus AHAP3 particles, 
NO-releasing AEAP3 exhibited greater antibacterial action. 
The increased bactericidal activity of NO-releasing AEAP3 
suggests that extended NO-release kinetics may be more bene-
ficial for killing periodontopathogens than a greater positive 
particle surface charge and enhanced particle-bacteria associa-
tion. Confocal microscopy confirmed more efficient NO deliv-
ery to A. actinomycetemcomitans from NO-releasing AEAP3 
versus AHAP3 particles (Fig. 3). While intracellular NO was 
detected for both NO-releasing particle systems after 30 min, 
the greater fluorescence signal observed for NO-releasing 
AEAP3 particles at 60 min indicates more accumulation of 
intracellular NO from AEAP3 versus AHAP3 particles. As 
such, NO-releasing AEAP3 particles more efficiently deliver 
bactericidal levels of NO within 120 min, resulting in cell death 
(Hetrick et al. 2008; Slomberg et al. 2013). The visualization of 
intracellular NO concentrations confirms the benefit of slower 
NO-release kinetics over greater (positive) particle surface 
charge for enhancing the bactericidal action of NO-releasing 
macromolecular scaffolds against periodontopathogens.
The improvement in the antibacterial activity of NO-releasing 
silica against periodontopathogens with extended NO-release 
kinetics was somewhat surprising as it contradicts previous 
reports. For example, Lu et al. (2013) observed that a greater 
initial NO flux and more rapid NO-release kinetics enhanced 
the bactericidal efficacy of silica-based NO release against 
P. aeruginosa. Of importance, P. aeruginosa uses the enzyme 
nitric oxide reductase (NOR) as a defense against NO-based 
host immunity (Kakishima et al. 2007), which functions as an 
NO detoxification mechanism by mitigating low concentrations 
of intracellular NO. Under such conditions, larger instantaneous 
NO concentrations are required to overload protective pro-
cesses and elicit NO-mediated death. Conversely, A. actinomy-
cetemcomitans and P. gingivalis do not possess these 
antioxidative pathways and are unable to effectively eliminate 
intracellular NO. Rather, as NO accumulates within the bacteria 
over time, NO-releasing silica particles that can associate with 
bacteria prior to releasing a majority of their NO payload (slow 
NO-releasing AEAP3 particles) more effectively deliver bacte-
ricidal levels of NO than fast NO-releasing systems that may 
release substantial amounts of NO prior to association with bac-
teria. The instantaneous NO concentration appears to be less 
critical for killing periodontal pathogens than total intracellular 
NO delivered over time. The benefit of extended NO-release 
kinetics for more effective periodontopathogen killing may 
influence the design of NO-releasing therapeutics for periodontal 
Figure 2. Cytotoxicity of nitric oxide (NO)–releasing and control 
silica particles against HGF-1 human gingival fibroblasts at the greatest 
MBC
2h
 values to kill periodontopathogens. The concentrations to kill 
Aggregatibacter actinomycetemcomitans were 8, 32, and 48 mg/mL for 
80 mol% N-(2-aminoethyl)-3-aminopropyltrimethoxysilane (AEAP3), 
60 mol% N-(6-aminohexyl)aminopropyltrimethoxysilane (AHAP3), and 
50 mol% 3-methylaminopropyltrimethoxysilane (MAP3), respectively. 
Viability measured as metabolic activity versus untreated cells. Error bars 
represent standard deviation of the mean. For all values, n = 4 replicate 
measurements. Asterisk indicates P < 0.05 using 2-tailed Student’s t test.
Figure 3. Confocal microscopy images of Aggregatibacter 
actinomycetemcomitans exposed to 1 mg/mL nitric oxide (NO)–releasing 
silica nanoparticles (50 mol% 3-methylaminopropyltrimethoxysilane 
[MAP3], 60 mol% N-(6-aminohexyl)aminopropyltrimethoxysilane 
[AHAP3], and 80 mol% N-(2-aminoethyl)-3-aminopropyltrimethoxysilane 
[AEAP3]) after (A) 30 min, (B) 60 min, and (C) 120 min of particle 
exposure. DAF-2 fluorescence is depicted as black in this image for 
clarity and represents intracellular NO concentrations.
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diseases treatments. The combination of extended NO-release 
kinetics and greater positive surface charge might further 
enhance bactericidal efficacy.
The cytotoxicity of NO-releasing and control silica particles 
was evaluated against HGF-1 cells at bactericidal concentrations. 
While the addition of NO release increased the toxicity of MAP3 
and AHAP3 particles, it was found to slightly decrease the cyto-
toxicity of AEAP3 particles. While NO-releasing AEAP3 parti-
cles demonstrated a general decrease in toxicity compared with 
the other NO-releasing systems, the increase in cell viability was 
not statistically significant from non-NO-releasing particles. The 
ability of HGF-1 cells to tolerate low instantaneous levels of 
intracellular NO, such as those provided by AEAP3, is attributed 
to the enzymatic breakdown of superoxide (O
2
–) by superoxide 
dismutase, an enzyme that limits the formation of reactive NO 
by-products and concomitantly mitigates the nitrosative and oxi-
dative stresses associated with NO-mediated killing (Fridovich 
1983). The increase in cell viability is likely the result of NO 
stimulating cell growth as reported previously (Papapetropoulos 
et al. 1997; Carpenter et al. 2012; Worley et al. 2014). The anti-
bacterial characteristics and low cytotoxicity of the NO-releasing 
AEAP3 system warrant further investigation into slow NO- 
releasing silica-based materials as periodontal therapeutics. 
Increasing the total NO payload while maintaining slow-release 
kinetics may prove optimal in the clinical implementation of 
NO-based oral therapeutics.
We previously reported reduced sensitivity of S. mutans to 
NO treatment compared with periodontopathogens (Backlund 
et al. 2014). S. mutans is a unique pathogen that generates NO 
from nitrite via nitrite reductase to protect itself in nitrite-rich 
acidic environments such as the mouth (Choudhury et al. 2007; 
Backlund et al. 2014). Clearly, S. mutans possesses a mechanism 
to mitigate intracellular NO, thus limiting the antibacterial activ-
ity of both NO and its reactive by-products. As larger levels of 
NO are required to eradicate this cariogenic bacteria, particles 
with greater total NO storage were employed. However, the 
NO-releasing 70% MAP3 particles were incapable of eradicat-
ing S. mutans at pH 7.4. We hypothesized that faster NO release 
might overload this protective mechanism and facilitate 
S. mutans killing. To accelerate the NO-release kinetics of 
MAP3, NO-release characterization and bacterial killing assays 
were conducted at lower pH (6.4) in addition to physiological 
pH 7.4. Indeed, at pH 6.4, NO-releasing MAP3 particles resulted 
in total S. mutans killing at 32 mg/mL. This was attributed to the 
combination of faster NO release and positive surface charge at 
lower pH, leading to more efficient delivery of bactericidal lev-
els of NO. Indeed, confocal microscopy confirmed more effi-
cient NO delivery at pH 6.4 over pH 7.4, with greater intracellular 
NO levels detectable after 60 min (Fig. 4). Of note, the suscepti-
bility of cariogenic bacteria to rapid NO release under acidic 
conditions may represent a viable method for the treatment of 
dental caries on short time scales (i.e., tooth brushing).
Conclusively, our study details the synthesis of ~150-nm 
NO-releasing silica nanoparticles with tunable NO-release 
kinetics and their antibacterial activity. Slower NO-release 
kinetics enhanced the bactericidal efficacy of NO-releasing 
silica particles against periodontopathogens while only 
minimally affecting human gingival fibroblast viability. The 
enhanced antibacterial action and reduced cytotoxicity for 
macromolecular NO-release scaffold that slowly releases NO 
warrant careful attention with respect to the development of 
NO-releasing therapeutics against periodontopathogens. A dif-
ferential sensitivity to NO-release totals and kinetics was 
observed between periodontopathogens and cariogenic bacte-
ria. The incorporation of additional biocides onto NO-releasing 
silica nanoparticles would be required to facilitate more com-
plete killing of S. mutans.
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